Bayer Advances Parkinson’s Cell And Gene Therapies Into First Human Studies

Recently-Acquired BlueRock and AskBio Move Ahead

 
• By Andrew McConaghie
  
Deep brain stimulation surgery for Parkinson's disease
BlueRock's therapy will involve the implanting of stem cells deep into the brains of Parkinson's disease patients, with the hope of restoring nerve cells and function. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category